From Molecular Codes to Rapid Diagnostic Kits: The Quiet Impact of Dr David Marlborough
Early curiosity in molecular structure
Long before rapid antigen tests became household items, David Marlborough was immersed in a very different scientific puzzle, the structural logic of life itself.
During his PhD and postdoctoral work in the 1970s, Dr Marlborough focused on polypeptide conformations and the emerging understanding of how genetic information translates into protein structure. His research, published in Biopolymers (1973) and later in Origins of Life (1980), explored patterns that hinted at a deeper biochemical order.
At the heart of this work was a striking observation:
A triplet codon with a central pyrimidine base codes for a hydrophobic amino acid, while one with a central purine base tends to code for a more hydrophilic amino acid.
It was a hypothesis that gestured toward a physicochemical logic underpinning the genetic code, a question Dr Marlborough intended to pursue further, but one that would remain an open thread as his career evolved.
A rare molecule and an enduring mystery
Alongside his work on genetic coding, Dr Marlborough also investigated a biochemical anomaly: poly-γ-D-glutamic acid, a rare naturally occurring polypeptide composed of D-amino acids.
This molecule, found as a protective coating on Bacillus anthracis (the anthrax bacterium), behaved unlike typical proteins.
One thing that resulted from the work… was that this polypeptide did not unfold, conformationally, as did other natural polypeptides when ionised, but retained an ordered structure.
This unusual stability may help explain the resilience and virulence of the bacterium. While Dr Marlborough stops short of drawing definitive conclusions, the implication is clear: molecular structure can have profound biological consequences.
Keith Williams looks on as fellow scientist David Marlborough shows off the TB detection device that has been backed by billionaire Bill Gates (The Australian Newspaper, n.d.)
A global research perspective
Marlborough’s early career also included international research experiences that broadened his scientific perspective. He worked on the anti-leukaemia enzyme L-asparaginase at Porton Down in the United Kingdom, and later investigated proteins within the angiotensin–bradykinin vasoactive system at the University of Miami in the United States.
These experiences helped shape a career that bridged fundamental biochemical research with applied medical science.
A shift from theory to application
After several years in academic research, Dr Marlborough made a decisive shift into commercial science, moving from theoretical investigations to applied medical technologies.
His focus turned to rapid diagnostic tests, an area that would grow in importance over the following decades.
I was principally involved with the investigation and production of the detecting agents in the rapid tests: the detecting antibody linked to colloidal gold.
Importantly, this work contributed to commercially produced rapid diagnostic tests for diseases including Dengue Fever, Malaria, and Poliomyelitis during his time at ICT Diagnostics and later Tyrian Diagnostics.
These antibody-gold conjugates form the backbone of many lateral flow assays, enabling fast, visual detection of disease markers. At the time, the work was largely behind the scenes: technical, precise, and far removed from public attention.
Quiet contributions to a global moment
That changed dramatically with the COVID-19 pandemic, when rapid diagnostic tests became a central tool in global public health.
Technologies that Dr Marlborough had worked on for years suddenly entered everyday life, allowing individuals to test at home and seek timely medical advice.
The greater uptake of rapid diagnostic tests… has been particularly evident with regard to COVID testing in recent times.
It was a moment that underscored the long arc of scientific contribution, from foundational chemistry to real-world impact, often decades in the making.
Reflecting on a scientific journey
Looking back, Dr Marlborough’s career traces a path from fundamental questions about life’s molecular code to technologies that support modern healthcare systems.
His early work raised questions that still resonate in contemporary research, while his later contributions helped shape tools now used worldwide.
Together, they reflect a career defined not by a single breakthrough, but by sustained, thoughtful engagement with chemistry in both theory and practice.
Thank you, Dr David, for showing us what real impact looks like.
Inspired? Find your community group with the RACI. Join us and start making your own story today.
Submit Your Story here: https://raci.org.au/resources/share-your-story
Further information
|
|
David Marlborough
Dr David Marlborough is a chemist whose career spans fundamental biochemical research and applied diagnostic innovation. His early work explored polypeptide structure and the physicochemical logic of the genetic code, while his later contributions helped advance rapid diagnostic technologies, including tests for diseases such as Dengue Fever, Malaria, and Poliomyelitis.
|
#Feature #MemberSpotlight #FellowSpotlight